PizeNews

Pize is an AI coding assistant for scientific computing and statistical analysis. It runs in Pize Code and Positron, and also ships as an SDK.

Pize logoPize.ai
Account
← All authors

PIZE · AUTHOR

Keran Sun

Cancer Immunology and Computational Analysis

Keran Sun works in cancer immunology and computational approaches to biomarker research. Areas of work include machine learning, single-cell sequencing, and multi-omics analysis. Selected publications cover gastric cancer, sepsis, and related clinical or public-health topics.

Focus areas

  • Cancer immunology
  • Machine-learning methods for biomarker research
  • Single-cell and multi-omics analysis
  • Reproducible computational analysis

Education

  • PhD, ImmunologyHebei Medical University2021–2025
  • M.M., Internal MedicineZhengzhou University2018–2021
  • M.B.B.S., Clinical MedicineXinxiang Medical University2013–2018

Publication record

Selected publications

Education and professional-background information is based on biographical information supplied to Pize. Publication citations link to publisher DOI records.

  1. Waiting for disaster: Australia's arboviral outbreak reveals inadequacies of surveillance systems

    The Lancet Microbe. 2025;6(12):101207.

    doi.org/10.1016/j.lanmic.2025.101207

  2. Rethinking decolonisation for individuals with cancer: lessons from the emergence of meticillin-resistant Staphylococcus epidermidis in intensive care units

    The Lancet Microbe. 2025;6(10):101195.

    doi.org/10.1016/j.lanmic.2025.101195

  3. Use of machine learning-based integration to develop an immune-related signature for improving prognosis in patients with gastric cancer

    Scientific Reports. 2023;13:7019.

    doi.org/10.1038/s41598-023-34291-9

  4. Use of machine learning-based integration to develop a monocyte differentiation-related signature for improving prognosis in patients with sepsis

    Molecular Medicine. 2023;29:37.

    doi.org/10.1186/s10020-023-00634-5

  5. Single-cell Sequence Analysis Combined with Multiple Machine Learning to Identify Markers in Sepsis Patients: LILRA5

    Inflammation. 2023;46(4):1236–1254.

    doi.org/10.1007/s10753-023-01803-8

  6. Role of ACLY in the development of gastric cancer under hyperglycemic conditions

    Quantitative Biology. 2024;12(1):100–116.

    doi.org/10.1002/qub2.36

  7. Dawning precision treatment for gastric cancer: The latest biomarkers

    Journal of Translational Internal Medicine. 2021;9(4):228–230.

    doi.org/10.2478/jtim-2021-0023

  8. EBV-Positive Gastric Cancer: Current Knowledge and Future Perspectives

    Frontiers in Oncology. 2020;10:583463.

    doi.org/10.3389/fonc.2020.583463

  9. Latest therapeutic target for gastric cancer: Anthrax toxin receptor 1

    World Journal of Gastrointestinal Oncology. 2021;13(4):216–222.

    doi.org/10.4251/wjgo.v13.i4.216